Differential Diagnosis and Management of Jaundice with Neutropenia, Cardiomyopathy, and Acute Kidney Injury

Primary Differential Considerations

Sepsis with multiorgan dysfunction is the most urgent consideration when jaundice, neutropenia, cardiomyopathy, and AKI present together, as bacterial infections can precipitate hepatorenal syndrome and cardiac dysfunction while causing bone marrow suppression 1, 2.
The combination of AKI with jaundice in the setting of infection carries particularly high mortality risk 3.
Advanced cirrhosis with hepatorenal syndrome (HRS-AKI) complicated by spontaneous bacterial peritonitis can present with this tetrad 4, 1, 2.

Evaluate for infection aggressively with blood cultures, urine cultures, chest radiography, and diagnostic paracentesis if ascites is present, as infection is the most common precipitant of HRS-AKI and multiorgan failure 1, 5, 6.
Perform urinalysis to detect hematuria, proteinuria (>500 mg/day), or abnormal sediment, which would suggest structural kidney disease rather than functional AKI 5, 3.
Consider urine biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL) to distinguish acute tubular necrosis from HRS-AKI in patients with cirrhosis 4, 3, 6.

Discontinue all nephrotoxic medications including NSAIDs, aminoglycosides, ACE inhibitors, ARBs, and contrast agents 4, 3, 6.
Hold diuretics immediately after AKI diagnosis, as continued use worsens outcomes 4, 3, 6.
Initiate empirical antibiotics if infection is suspected, as bacterial infections are the most common precipitant of multiorgan failure and delay in treatment increases mortality 1, 6.
Administer albumin 1 g/kg/day (maximum 100 g) for two consecutive days if hypovolemia or cirrhosis with AKI is suspected, while carefully monitoring for pulmonary edema 1, 2, 5, 6.

Do not delay treatment of underlying infection while awaiting culture results, as sepsis is the most reversible cause of this presentation and delay significantly increases mortality 1, 6.
Do not continue nephrotoxic medications even if they seem clinically necessary; the risk-benefit ratio strongly favors discontinuation in AKI 6.
Avoid fluid overload when administering albumin, particularly in patients with cardiomyopathy, as pulmonary edema can be life-threatening 1, 2, 5.